Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
New standards launched to improve public involvement in research
New national standards to improve the quality of public involvement in research.
Old sales techniques are history and sales forces must adapt
Despite all the rhetoric about multichannel marketing, patient centricity and the inexorable rise of digital, the most effective sales channel is still standing ‘two...
How to concentrate sales efforts in the right place
Right place, right time In part two of a series looking at the effective use of data, Dr Graham Leask addresses how to concentrate sales...
Sales force awakens to boost ROI
Sales force awakens
Karen Bell, Director of Business Development at Ashfield Commercial and Clinical UK, on maximising return on investment. Sales force effectiveness (SFE) is about...
The rise of digital marketing: pharma and social media
Social media is a prerequisite for most businesses, but how has the historically reticent pharma industry been adapting?
Graeme Smith
Managing Partner, Fortis Pharma Consulting
The highly–regulated...
Marketing Focus: the shift from treatment to prevention
Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene
Dr Graham Leask and Stewart Adkins...
Marketing Focus: helping modern marketeers to thrive
PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...
Latest articles
NHS England fails to meet life-saving rare disease commitment
This Rare Disease Day, the Genetic Alliance calls on NHS England after it fails to meet its life-saving rare disease commitment. Two years ago, NHS...
Pharma approvals and appraisals summary
This week's Pf pharma approvals and appraisals summary includes Roche, Celgene, GSK and Innoviva, Takeda, Novartis and Seqirus. UK NICE has published draft guidance that does...
European partnerships invest £27.4m to accelerate cancer research
Cancer Research UK and its European partners, Fondazione AIRC and Asociación Española Contra el Cáncer (AECC), are to invest £27.4 million into seven new...
Popular articles
Clover and GSK collaborate on coronavirus vaccine candidate
Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has entered into a...
European partnerships invest £27.4m to accelerate cancer research
Cancer Research UK and its European partners, Fondazione AIRC and Asociación Española Contra el Cáncer (AECC), are to invest £27.4 million into seven new...
New coronavirus guidelines for pharmacists
The International Pharmaceutical Federation (FIP) has issued new international coronavirus guidelines for pharmacists covering how they should deal with the latest coronavirus outbreak. The roles...
Pharma approvals and appraisals summary
This week's Pf pharma approvals and appraisals summary includes Roche, Celgene, GSK and Innoviva, Takeda, Novartis and Seqirus. UK NICE has published draft guidance that does...
First coronavirus clinical data published in The Lancet
The Lancet has published the first coronavirus clinical data from initial cases of the infection in China. The 2019 novel coronavirus (2019-nCoV) appears to cause...